These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26401934

  • 21. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT, Yu P, Sun J, Schuh K, Case M, Witte MM, Hochstetler H, Hake A, Alzheimer's Disease Neuroimaging Initiative.
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [Abstract] [Full Text] [Related]

  • 22. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
    Tateno A, Sakayori T, Kawashima Y, Higuchi M, Suhara T, Mizumura S, Mintun MA, Skovronsky DM, Honjo K, Ishihara K, Kumita S, Suzuki H, Okubo Y.
    Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
    [Abstract] [Full Text] [Related]

  • 23. Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers.
    Xu L, Wu X, Li R, Chen K, Long Z, Zhang J, Guo X, Yao L, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2016 May; 51(4):1045-56. PubMed ID: 26923024
    [Abstract] [Full Text] [Related]

  • 24. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
    Tosun D, Schuff N, Jagust W, Weiner MW, Alzheimer''s Disease Neuroimaging Initiative.
    Neurodegener Dis; 2016 May; 16(1-2):87-94. PubMed ID: 26560336
    [Abstract] [Full Text] [Related]

  • 25. Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment.
    Blautzik J, Kotz S, Brendel M, Sauerbeck J, Vettermann F, Winter Y, Bartenstein P, Ishii K, Rominger A, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2018 May; 65(3):781-791. PubMed ID: 28697560
    [Abstract] [Full Text] [Related]

  • 26. Two-year follow-up of amyloid deposition in patients with Alzheimer's disease.
    Engler H, Forsberg A, Almkvist O, Blomquist G, Larsson E, Savitcheva I, Wall A, Ringheim A, Långström B, Nordberg A.
    Brain; 2006 Nov; 129(Pt 11):2856-66. PubMed ID: 16854944
    [Abstract] [Full Text] [Related]

  • 27. The evaluation of brain perfusion SPECT using an easy Z-score imaging system in the mild cognitive impairment subjects with brain amyloid-β deposition.
    Takemaru M, Kimura N, Abe Y, Goto M, Matsubara E.
    Clin Neurol Neurosurg; 2017 Sep; 160():111-115. PubMed ID: 28715708
    [Abstract] [Full Text] [Related]

  • 28. A biomarker study in long-lasting amnestic mild cognitive impairment.
    Cerami C, Dodich A, Iannaccone S, Magnani G, Santangelo R, Presotto L, Marcone A, Gianolli L, Cappa SF, Perani D.
    Alzheimers Res Ther; 2018 Apr 25; 10(1):42. PubMed ID: 29695292
    [Abstract] [Full Text] [Related]

  • 29. Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype.
    Espinosa A, Alegret M, Pesini P, Valero S, Lafuente A, Buendía M, San José I, Ibarria M, Tejero MA, Giménez J, Ruiz S, Hernández I, Pujadas F, Martínez-Lage P, Munuera J, Arbizu J, Tárraga L, Hendrix SB, Ruiz A, Becker JT, Landau SM, Sotolongo-Grau O, Sarasa M, Boada M, AB255 Study Group, Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2017 Apr 25; 57(2):447-459. PubMed ID: 28269787
    [Abstract] [Full Text] [Related]

  • 30. Comparison of MRI based and PET template based approaches in the quantitative analysis of amyloid imaging with PIB-PET.
    Edison P, Carter SF, Rinne JO, Gelosa G, Herholz K, Nordberg A, Brooks DJ, Hinz R.
    Neuroimage; 2013 Apr 15; 70():423-33. PubMed ID: 23261639
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
    Shin J, Lee SY, Kim SJ, Kim SH, Cho SJ, Kim YB.
    Neuroimage; 2010 Aug 15; 52(2):488-96. PubMed ID: 20385246
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Croteau E, Castellano CA, Fortier M, Bocti C, Fulop T, Paquet N, Cunnane SC.
    Exp Gerontol; 2018 Jul 01; 107():18-26. PubMed ID: 28709938
    [Abstract] [Full Text] [Related]

  • 37. Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study.
    Delrieu J, Desmidt T, Camus V, Sourdet S, Boutoleau-Bretonnière C, Mullin E, Vellas B, Payoux P, Lebouvier T, Alzheimer's Disease Neuroimaging Initiative.
    Int J Geriatr Psychiatry; 2015 May 01; 30(5):470-7. PubMed ID: 24953008
    [Abstract] [Full Text] [Related]

  • 38. Five-year follow-up of 11C-PIB uptake in Alzheimer's disease and MCI.
    Kemppainen NM, Scheinin NM, Koivunen J, Johansson J, Toivonen JT, Någren K, Rokka J, Karrasch M, Parkkola R, Rinne JO.
    Eur J Nucl Med Mol Imaging; 2014 Feb 01; 41(2):283-9. PubMed ID: 24072346
    [Abstract] [Full Text] [Related]

  • 39. Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI.
    He W, Liu D, Radua J, Li G, Han B, Sun Z.
    Cell Biochem Biophys; 2015 Jan 01; 71(1):17-26. PubMed ID: 25370296
    [Abstract] [Full Text] [Related]

  • 40. Left lateralized cerebral glucose metabolism declines in amyloid-β positive persons with mild cognitive impairment.
    Weise CM, Chen K, Chen Y, Kuang X, Savage CR, Reiman EM, Alzheimer's Disease Neuroimaging Initiative.
    Neuroimage Clin; 2018 Jan 01; 20():286-296. PubMed ID: 30101060
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.